Literature DB >> 7947493

Expression of the fos oncogene in basal cell carcinoma.

A Urabe1, J Nakayama, S Taniguchi, R Kuroki, Y Hori.   

Abstract

Using immunohistochemical technique and Western blot analysis, we demonstrated the increased expression of the c-fos oncogene in the infiltrative type of solid basal cell carcinoma (BCC), but low or no expression in the circumscribed type of solid BCC. The infiltrative type is called aggressive BCC and had been shown to exhibit a higher rate of recurrence than the circumscribed type. Our results indicate that increased expression of the fos oncogene is closely related to the invasive ability of the tumor cells.

Entities:  

Mesh:

Year:  1994        PMID: 7947493     DOI: 10.1016/0923-1811(94)90321-2

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  2 in total

1.  Silibinin and its 2,3-dehydro-derivative inhibit basal cell carcinoma growth via suppression of mitogenic signaling and transcription factors activation.

Authors:  Cynthia Tilley; Gagan Deep; Chapla Agarwal; Michael F Wempe; David Biedermann; Kateřina Valentová; Vladimir Kren; Rajesh Agarwal
Journal:  Mol Carcinog       Date:  2014-12-09       Impact factor: 4.784

2.  Immunoreactivity for alpha-smooth muscle actin characterizes a potentially aggressive subgroup of little basal cell carcinomas.

Authors:  L Pilloni; P Bianco; C Manieli; G Senes; P Coni; L Atzori; N Aste; G Faa
Journal:  Eur J Histochem       Date:  2009-06-29       Impact factor: 3.188

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.